developed a nomogram using TCGA data, including age, WHO grade, Karnofsky performance status, and IDH-based molecular subtype; this model was externally validated in the Ohio Brain Tumor Study cohort, offering reliable individualized survival estimates (50). This evidence concerns the gene IDH1 and brain neoplasm.